Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2286.7 and 2364.6
| Intraday Target 1 | 2226.5 |
| Intraday Target 2 | 2269 |
| Intraday Target 3 | 2304.4 |
| Intraday Target 4 | 2346.9 |
| Intraday Target 5 | 2382.3 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 02 April 2026 | 2311.50 (-0.76%) | 2293.10 | 2261.90 - 2339.80 | 1.6348 times | Wed 01 April 2026 | 2329.20 (2.02%) | 2305.00 | 2291.20 - 2401.90 | 1.0487 times | Mon 30 March 2026 | 2283.00 (1.04%) | 2259.50 | 2217.60 - 2296.90 | 1.9381 times | Fri 27 March 2026 | 2259.50 (-2.67%) | 2320.60 | 2255.10 - 2330.40 | 0.9154 times | Wed 25 March 2026 | 2321.60 (0.54%) | 2310.00 | 2305.20 - 2352.50 | 1.3139 times | Tue 24 March 2026 | 2309.10 (1.31%) | 2301.00 | 2284.60 - 2340.00 | 0.7679 times | Mon 23 March 2026 | 2279.20 (-4.43%) | 2353.40 | 2269.10 - 2364.90 | 0.7623 times | Fri 20 March 2026 | 2384.80 (0.34%) | 2376.80 | 2362.50 - 2416.00 | 0.8803 times | Thu 19 March 2026 | 2376.70 (-2.5%) | 2401.00 | 2372.40 - 2419.60 | 0.3441 times | Wed 18 March 2026 | 2437.60 (0.33%) | 2428.90 | 2418.20 - 2472.00 | 0.3945 times | Tue 17 March 2026 | 2429.60 (1.11%) | 2404.90 | 2396.00 - 2440.00 | 0.466 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2264.55 and 2448.85
| Weekly Target 1 | 2126.03 |
| Weekly Target 2 | 2218.77 |
| Weekly Target 3 | 2310.3333333333 |
| Weekly Target 4 | 2403.07 |
| Weekly Target 5 | 2494.63 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 1.0082 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 0.8201 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.5977 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.8023 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.7758 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.7745 times | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 0.8569 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 2.2213 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 1.1359 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 1.0071 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.3035 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2286.7 and 2426.7
| Monthly Target 1 | 2185.1 |
| Monthly Target 2 | 2248.3 |
| Monthly Target 3 | 2325.1 |
| Monthly Target 4 | 2388.3 |
| Monthly Target 5 | 2465.1 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 02 April 2026 | 2311.50 (1.25%) | 2305.00 | 2261.90 - 2401.90 | 0.1147 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6698 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9774 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8731 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.4269 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1902 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7728 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.2311 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.7037 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 1.0402 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 2.0812 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2013.45 and 2515.65
| Yearly Target 1 | 1914.1 |
| Yearly Target 2 | 2112.8 |
| Yearly Target 3 | 2416.3 |
| Yearly Target 4 | 2615 |
| Yearly Target 5 | 2918.5 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 02 April 2026 | 2311.50 (-6.55%) | 2476.00 | 2217.60 - 2719.80 | 0.2315 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6505 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2534 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2527 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7276 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9705 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0831 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4633 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2356 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1318 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.132 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
But this trend seems to be weakening.Price is below an important level of 2347.43 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears undecisive. It can be Bearish or Bullish. You should wait for the first half to take a decision on this stock. If it shows signs of weakness in the latter half, then this trend can continue tomorrow as well. Similarly, if it shows signs of strength in the latter half, then this trend can continue in the next trading session as well.
Munafa value: 31 as on Thu 02 April 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2402 and price is deviating by 86 points
Upper Bollinger band is at 2573 and lower is at 2231, while middle bands are at 2316 and 2487
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2315.42 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2300.96 |
| 12 day DMA | 2343.73 |
| 20 day DMA | 2401.41 |
| 35 day DMA | 2491.78 |
| 50 day DMA | 2462.06 |
| 100 day DMA | 2478.31 |
| 150 day DMA | 2565.7 |
| 200 day DMA | 2697.18 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2311.37 | 2311.31 | 2302.36 |
| 12 day EMA | 2347.4 | 2353.93 | 2358.43 |
| 20 day EMA | 2385.87 | 2393.7 | 2400.49 |
| 35 day EMA | 2410.27 | 2416.08 | 2421.2 |
| 50 day EMA | 2438.36 | 2443.54 | 2448.2 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2300.96 | 2300.48 | 2290.48 |
| 12 day SMA | 2343.73 | 2353.13 | 2367.73 |
| 20 day SMA | 2401.41 | 2412.47 | 2424.59 |
| 35 day SMA | 2491.78 | 2497.63 | 2502.05 |
| 50 day SMA | 2462.06 | 2462.42 | 2462.75 |
| 100 day SMA | 2478.31 | 2481.25 | 2484.55 |
| 150 day SMA | 2565.7 | 2568.95 | 2571.96 |
| 200 day SMA | 2697.18 | 2702.22 | 2707.47 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 38.35
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 40.99
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
